Continued rising drug prices, as well as shortages for many critical medications, are impacting patient care and putting strains on hospital budgets and operations. That’s why hospitals and health systems have gathered to create Civica Rx, a not-for-profit generic drug company that is disrupting the pharmaceutical market. Chip spoke with Martin VanTrieste, Civica’s President & CEO, about why and how the company was formed, the success it is enjoying so far, and if other drug companies will follow its lead. […]
Read More… from Disrupting the Drug Market With Martin Van Trieste
Addressing high drug costs, improving public health and ensuring patients are protected from surprise bills are important goals and FAH will continue to work with Congress towards long-term, material solutions. We appreciate Chairman Alexander and […]
Read More… from FAH Reacts to Draft Legislation Released by HELP Committee
FAH sent a letter to the House Ways and Means Committee Chairman Richard Neal (D-MA) and Ranking Member Kevin Brady (R-TX) in support of the Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act. In […]
Read More… from FAH Supports STAR Act
